Lifecore Biomedical, Inc. De (LFCR) Total Liabilities (2011 - 2025)

Lifecore Biomedical has reported Total Liabilities for 15 years, with the latest figure at $191.9 million in Q2 2025.

• On a quarterly basis, Total Liabilities fell 4.07% year-over-year to $191.9 million in Q2 2025; TTM through May 2025 was $191.9 million, a 4.07% decrease from a year earlier, with the FY2025 full-year figure at $191.9 million, down 4.07% from the prior year.
• Total Liabilities was $191.9 million for Q2 2025 at Lifecore Biomedical, up from $190.3 million in the prior quarter.
• The five-year high for Total Liabilities was $304.7 million in Q1 2021, with the low at $163.1 million in Q1 2023.
• Average Total Liabilities over 5 years is $214.4 million, with a median of $201.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities slumped 40.36% in 2022, then advanced 16.9% in 2023.
• Over 5 years, Total Liabilities stood at $265.9 million in 2021, then fell by 22.96% to $204.8 million in 2022, then dropped by 0.66% to $203.5 million in 2023, then slipped by 3.86% to $195.6 million in 2024, then decreased by 1.9% to $191.9 million in 2025.
• The last three Total Liabilities figures came in at $191.9 million (Q2 2025), $190.3 million (Q1 2025), and $195.6 million (Q4 2024), per Business Quant data.